Sequence-based prediction for vaccine strain selection and identification of antigenic variability in foot-and-mouth disease virus

PLoS Computational Biology

Volumn 6, Issue 12, 2010, Pages

  Reeve, Richard ^a,b   Blignaut, Belinda ^c,d   Esterhuysen, Jan J ^c   Opperman, Pamela ^c,d   Matthews, Louise ^a,b   Fry, Elizabeth E ^e   de Beer, Tjaart A P ^d,h   Theron, Jacques ^d   Rieder, Elizabeth ^f   Vosloo, Wilna ^c,i   O'Neill, Hester G ^g   Haydon, Daniel T ^a,b   Maree, Francois F ^c  

^a UNIVERSITY OF GLASGOW   (United Kingdom)

^b UNIVERSITY OF GLASGOW   (United Kingdom)

^c ONDERSTEPOORT VETERINARY INSTITUTE   (South Africa)

^d UNIVERSITY OF PRETORIA   (South Africa)

^e The Henry Wellcome Building for Genomic Medicine   (United Kingdom)

^f PLUM ISLAND ANIMAL DISEASE CENTER   (United States)

^g NORTH WEST UNIVERSITY   (South Africa)

^h EUROPEAN BIOINFORMATICS INSTITUTE   (United Kingdom)

ⁱ CSIRO   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

DISEASE CONTROL; DISEASES; EPITOPES; FORECASTING; VIRUSES;

ANTIGENICS; CROSS-REACTIVITY; FOOT-AND-MOUTH DISEASE VIRUS; INFECTIOUS DISEASE; NEUTRALISATION; SEROTYPES; STRAIN IDENTIFICATION; STRAIN SELECTION; UNSOLVED PROBLEMS; VACCINE STRAINS;

VACCINES;

EPITOPE; FOOT AND MOUTH DISEASE VACCINE; VIRUS PROTEIN; CAPSID PROTEIN; NEUTRALIZING ANTIBODY; VIRUS VACCINE;

ANTIGENIC VARIATION; ARTICLE; COMPARATIVE EFFECTIVENESS; COMPUTER MODEL; CONTROLLED STUDY; CROSS REACTION; DRUG SCREENING; FOOT AND MOUTH DISEASE; FOOT AND MOUTH DISEASE VIRUS; INFECTION CONTROL; INFECTION PREVENTION; INTERMETHOD COMPARISON; MOLECULAR PHYLOGENY; NONHUMAN; NUCLEOTIDE SEQUENCE; PREDICTION; SEQUENCE ANALYSIS; SEROLOGY; SEROTYPE; STATISTICAL MODEL; STRAIN DIFFERENCE; STRAIN IDENTIFICATION; STRUCTURE ANALYSIS; VACCINE PRODUCTION; VIRUS NEUTRALIZATION; VIRUS STRAIN; AFRICA; ANIMAL; BIOLOGICAL MODEL; BIOLOGY; BLOOD; BUFFALO; CATTLE; CLUSTER ANALYSIS; COMPUTER SIMULATION; GENETICS; METHODOLOGY; PHYLOGENY; SEQUENCE ALIGNMENT; VIROLOGY;

FOOT-AND-MOUTH DISEASE VIRUS; MIRIDAE;

AFRICA, SOUTHERN; ANIMALS; ANTIBODIES, NEUTRALIZING; ANTIGENIC VARIATION; BUFFALOES; CAPSID PROTEINS; CATTLE; CLUSTER ANALYSIS; COMPUTATIONAL BIOLOGY; COMPUTER SIMULATION; EPITOPES; FOOT-AND-MOUTH DISEASE; FOOT-AND-MOUTH DISEASE VIRUS; MODELS, IMMUNOLOGICAL; PHYLOGENY; SEQUENCE ALIGNMENT; SEQUENCE ANALYSIS, RNA; VIRAL VACCINES;

EID: 78651227553     PISSN: 1553734X     EISSN: 15537358     Source Type: Journal    
DOI: 10.1371/journal.pcbi.1001027     Document Type: Article

References (47)

1. Holland J, Spindler K, Horodyski F, Grabau E, Nichol S, et al. (1982) Rapid Evolution of RNA genomes. Science 215: 1577-1585.
2. Mattion N, Konig G, Seki C, Smitsaart E, Maradei E, et al. (2004) Reintroduction of foot-and-mouth disease in Argentina: characterisation of the isolates and development of tools for the control and eradication of the disease. Vaccine 22: 4149-4162.
3. Garten R, Davis CT, Russell C, Shu B, Lindstrom S, et al. (2009) Antigenic and Genetic Characteristics of Swine-Origin 2009 A(H1N1) Influenza Viruses Circulating in Humans. Science 325: 197-201.
4. Paton D, Valarcher J, Bergmann I, Matlho O, Zakharov V, et al. (2005) Selection of foot and mouth disease vaccine strains - a review. Rev Sci Tech 24: 981-993.
5. Smith DJ, Lapedes AS, de Jong JC, Bestebroer TM, Rimmelzwaan GF, et al. (2004) Mapping the antigenic and genetic evolution of influenza virus. Science 305: 371-376.
6. OIE (2008) Manual of Diagnostic Tests and Vaccines for Terrestrial Animals. Section 2.1.5. Foot and mouth disease: Version adopted by the World Assembly of Delegates of the OIE in May 2009. Available: http://www.oie.int/eng/normes/mmanual/A_index.htm. Accessed 8 November 2010.
7. Knowles N, Samuel A (2003) Molecular epidemiology of foot-and-mouth disease virus. Virus Res 91: 65-80.
8. Bastos A, Haydon D, Forsberg R, Knowles N, Anderson E, et al. (2001) Genetic heterogeneity of SAT-1 type foot-and-mouth disease viruses in southern Africa. Arch Virol 146: 1537-1551.
9. Bastos A, Haydon D, Sangare O, Boshoff C, Edrich J, et al. (2003) The implications of virus diversity within the SAT 2 serotype for control of foot-andmouth disease in sub-Saharan Africa. J Gen Virol 84: 1595-1606.
10. Bastos ADS, Anderson EC, Bengis RG, Keet DF, Winterbach H, et al. (2003) Molecular epidemiology of SAT3-type foot-and-mouth disease. Virus Genes 27: 283-290.
11. Vosloo W, Bastos AD, Kirkbride E, Esterhuysen J, van Rensburg DJ, et al. (1996) Persistent infection of African buffalo (Syncerus caffer) with SAT-type foot-and-mouth disease viruses: rate of fixation of mutations, antigenic change and interspecies transmission. J Gen Virol 77: 1457-1467.
12. Vosloo W, Kirkbride E, Bengis RG, Keet DF, Thomson GR (1995) Genome variation in the SAT types of foot-and-mouth disease viruses prevalent in buffalo (Syncerus caffer) in the Kruger National Park and other regions of southern Africa, 1986-93. Epidemiol Infect 114: 203-218.
13. Vosloo W, Knowles NJ, Thomson GR (1992) Genetic relationships between southern African SAT-2 isolates of foot-and-mouth-disease virus. Epidemiol Infect 109: 547-558.
14. Crowther J, Rowe C, Butcher R (1993) Characterization of monoclonal antibodies against a type SAT 2 foot-and-mouth disease virus. Epidemiol Infect 111: 391-406.
15. Barnett P, Ouldridge E, Rowlands D, Brown F, Parry N (1989) Neutralizing epitopes of type O foot-and-mouth disease virus. I. Identification and characterization of three functionally independent, conformational sites. J Gen Virol 70 (Pt 6): 1483-1491.
16. Crowther J, Farias S, Carpenter W, Samuel A (1993) Identification of a fifth neutralizable site on type O foot-and-mouth disease virus following characterization of single and quintuple monoclonal antibody escape mutants. J Gen Virol 74: 1547-1553.
17. Kitson J, McCahon D, Belsham G (1990) Sequence analysis of monoclonal antibody resistant mutants of type O foot and mouth disease virus: evidence for the involvement of the three surface exposed capsid proteins in four antigenic sites. Virology 179: 26-34.
18. Baxt B, Vakharia V, Moore D, Franke A, Morgan D (1989) Analysis of neutralizing antigenic sites on the surface of type A12 foot-and-mouth disease virus. J Virol 63: 2143-2151.
19. Bolwell C, Brown A, Barnett P, Campbell R, Clarke B, et al. (1989) Host cell selection of antigenic variants of foot-and-mouth disease virus. J Gen Virol 70: 45-57.
20. Lea S, Hernandez J, Blakemore W, Brocchi E, Curry S, et al. (1994) The structure and antigenicity of a type C foot-and-mouth disease virus. Structure 2: 123-139.
21. Mateu MG (1995) Antibody recognition of picornaviruses and escape from neutralization: a structural view. Virus Res 38: 1-24.
22. Saiz JC, Gonzalez MJ, Borca MV, Sobrino F, Moore DM (1991) Identification of neutralizing antigenic sites on VP1 and VP2 of type A5 foot-and-mouth disease virus, defined by neutralization-resistant variants. J Virol 65: 2518-2524.
23. Thomas A, Woortmeijer R, Barteling S, Meloen R (1988) Evidence for more than one important, neutralizing site on foot-and-mouth disease virus. Brief report. Arch Virol 99: 237-242.
24. Thomas A, Woortmeijer R, Puijk W, Barteling S (1988) Antigenic sites on footand- mouth disease virus type A10. J Virol 62: 2782-2789.
25. Rweyemamu M, Booth J, Head M, Pay T (1978) Microneutralization tests for serological typing and subtyping of foot-and-mouth disease virus strains. J Hyg (Lond) 81: 107-123.
26. Parida S, Oh Y, Reid SM, Cox S, Statham RJ, et al. (2006) Interferon-gamma production in vitro from whole blood of foot-and-mouth disease virus (FMDV) vaccinated and infected cattle after incubation with inactivated FMDV. Vaccine 24: 964-969.
27. Samuel A, Ouldridge EJ, Arrowsmith AE, Kitching RP, Knowles N (1990) Antigenic analysis of serotype O foot-and-mouth disease virus isolates from the Middle East, 1981 to 1988. Vaccine 8: 390-396.
28. Barnett P, Samuel A, Statham R (2001) The suitability of the 'emergency' footand- mouth disease antigens held by the International Vaccine Bank within a global context. Vaccine 19: 2107-2117.
29. Rweyemamu M (1984) Antigenic variation in foot-and-mouth disease: studies based on the virus neutralization reaction. J Biol Stand 12: 323-337.
30. Rweyemamu M, Hingley P (1984) Food and mouth disease virus strain differentiation: analysis of the serological data. J Biol Stand 12: 225-229.
31. Fisher RA (1970) Statistical Methods for Research Workers, 14th Edition. Edinburgh: Oliver & Boyd. pp 378.
32. Holm S (1979) A Simple Sequentially Rejective Multiple Test Procedure. Scand Stat Theory Appl 6: 65-70.
33. Mattion N, Goris N, Willems T, Robiolo B, Maradei E, et al. (2009) Some guidelines for determining foot-and-mouth disease vaccine strain matching by serology. Vaccine 27: 741-747.
34. Lee M-S, Chen M-C, Liao Y-C, Hsiung CA (2007) Identifying potential immunodominant positions and predicting antigenic variants of influenza A/ H3N2 viruses. Vaccine 25: 8133-8139.
35. Liao Y-C, Lee M-S, Ko C-Y, Hsiung CA (2008) Bioinformatics models for predicting antigenic variants of influenza A/H3N2 virus. Bioinformatics 24: 505-512.
36. Bastos AD (1998) Detection and characterization of foot-and-mouth disease virus in sub-Saharan Africa. Onderstepoort J Vet Res 65: 37-47.
37. Beck E, Strohmaier K (1987) Subtyping of European foot-and-mouth disease virus strains by nucleotide sequence determination. J Virol 61: 1621-1629.
38. Boom R, Sol CJ, Salimans MM, Jansen CL, Wertheim-van Dillen PM, et al. (1990) Rapid and simple method for purification of nucleic acids. J Clin Microbiol 28: 495-503.
39. van Rensburg HG, Nel LH (1999) Characterization of the structural-proteincoding region of SAT 2 type foot-and-mouth disease virus. Virus Genes 19: 229-233.
40. Shapiro B, Rambaut A, Drummond A (2006) Choosing appropriate substitution models for the phylogenetic analysis of protein-coding sequences. Mol Biol Evol 23: 7-9.
41. Suchard M, Weiss R, Sinsheimer J (2001) Bayesian selection of continuous-time Markov chain evolutionary models. Mol Biol Evol 18: 1001-1013.
42. Drummond AJ, Rambaut A (2007) BEAST: Bayesian evolutionary analysis by sampling trees. BMC Evol Biol 7: 214.
43. Yates F (1934) The analysis of multiple classifications with unequal numbers in the different classes. J Am Stat Assoc 29: 51-66.
44. R Development Core Team (2010) R: A Language and Environment for Statistical Computing. Vienna, Austria. Available: http://www.r-project.org. Accessed 8 November 2010.
45. Lee M, Chen J (2004) Predicting antigenic variants of influenza A/H3N2 viruses. Emerg Infect Dis 10: 1385-1390.
46. Poon AFY, Lewis FI, Pond SLK, Frost SDW (2007) An evolutionary-network model reveals stratified interactions in the V3 loop of the HIV-1 envelope. PLoS Comput Biol 3: e231. doi:10.1371/journal.pcbi.0030231.
47. Felsenstein J (1985) Phylogenies and the Comparative Method. Am Nat 125: 1-15.